Evidence map›Paper›PMID 40144674›Full record

ReviewACS catalysis2025

Catalysis in the Excited State: Bringing Innate Transition Metal Photochemistry into Play.

Fabio Juliá

Abstract readReview
In one paragraph

Review in ACS catalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Visible-Light Mediated Activation of 1,3-Dienes and Allenes via Energy Transfers.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  13. LMCT-Driven Iron Photocatalysis: Mechanistic Insights and Synthetic Applications.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  14. Privileged Chiral Photocatalysts.Angewandte Chemie (International ed. in English) · 2025
    Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fabio JuliáFacultad de Química, Centro de Investigación Multidisciplinar Pleiades-Vitalis, Universidad de Murcia, Campus de Espinardo, 30100 Murcia, Spain.ORCID https://orcid.org/0000-0001-8903-4482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transition metal catalysis is an indispensable tool for organic synthesis that has been harnessed, modulated, and perfected for many decades by careful selection of metal centers and ligands, giving rise to synthetic methods with unparalleled efficiency and chemoselectivity. Recent developments have demonstrated how light irradiation can also be recruited as a powerful tool to dramatically alter the outcome of catalytic reactions, providing access to innovative pathways with remarkable synthetic potential. In this context, the adoption of photochemical conditions as a mainstream strategy to drive organic reactions has unveiled exciting opportunities to exploit the rich excited-state framework of transition metals for catalytic applications. This Perspective examines advances in the application of transition metal complexes as standalone photocatalysts, exploiting the innate reactivity of their excited states beyond their common use as photoredox catalysts. An account of relevant examples is dissected to provide a discussion on the electronic reorganization, the orbitals involved, and the associated reactivity of different types of excited states. This analysis aims to provide practitioners with fundamental principles and guiding strategies to understand, design, and apply light-activation strategies to homogeneous transition metal catalysis for organic synthesis.

Identifiers

PMID40144674
PMCPMC11934144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.